24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
CISLIEVA 10MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | CISLIEVA 10MG |
|---|---|
| Composition | Cisplatin Injection IP 10 MG |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
CISLIEVA 10MG (Cisplatin Injection IP 10 MG) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
CISLIEVA 10 MG (Cisplatin Injection IP 10 mg) is a prescription anticancer medicine containing Cisplatin 10 mg, a platinum-based chemotherapy agent used in the treatment of a wide range of solid tumors. Cisplatin belongs to the class of Platinum Coordination Compounds, which work by damaging the DNA of cancer cells, preventing them from growing, dividing, and spreading throughout the body.
Cisplatin is one of the most established and effective chemotherapy medicines in oncology. It acts by forming cross-links within cancer cell DNA, disrupting normal cellular replication and triggering cancer cell death. This mechanism helps control tumor growth and supports improved treatment outcomes in various cancers.
CISLIEVA 10 MG is commonly administered as part of combination chemotherapy regimens and is frequently used alongside other anticancer medicines or radiation therapy depending on the patient's diagnosis and treatment plan.
The 10 mg presentation is often utilized for individualized dosing, dose adjustments, combination therapy protocols, and treatment schedules requiring precise dose calculations.
CISLIEVA 10 MG is commonly prescribed for:
Manufactured according to stringent pharmaceutical quality standards, CISLIEVA 10 MG is designed to deliver consistent quality, safety, and therapeutic effectiveness.
Patients receiving Cisplatin therapy require regular monitoring of kidney function, blood counts, electrolyte levels, and hearing assessments to ensure optimal treatment outcomes and safety.
Due to its proven efficacy across multiple cancer types, CISLIEVA 10 MG remains an important component of modern oncology treatment protocols.
CISLIEVA 10 MG (Cisplatin Injection IP 10 mg) is primarily used in the treatment and management of various cancers.
Cisplatin is a key medicine in highly effective treatment regimens for testicular cancer.
The medicine is widely used in advanced and recurrent ovarian cancer treatment.
Doctors frequently prescribe Cisplatin as part of chemotherapy protocols for bladder cancer.
The medicine is used in both non-small cell and small cell lung cancer treatment programs.
Cisplatin is commonly administered with radiotherapy and other chemotherapy agents.
The medicine is widely used in concurrent chemoradiation treatment regimens.
Cisplatin may be incorporated into treatment plans for several other advanced cancers.
Cisplatin belongs to a class of medicines known as Platinum-Based Anticancer Agents.
CISLIEVA works by:
This mechanism helps reduce cancer spread and supports effective disease management.
Like all medicines, CISLIEVA 10 MG may cause side effects in some patients. The severity and frequency of side effects vary among individuals.
Digestive discomfort is among the most frequently reported side effects.
Weakness and tiredness may occur during treatment.
Reduced appetite may affect nutritional intake.
Cisplatin may affect kidney function and requires regular monitoring.
The medicine may reduce white blood cells, red blood cells, and platelet counts.
Some patients may experience hearing impairment or ringing in the ears (tinnitus).
Changes in magnesium, potassium, and calcium levels may occur.
Numbness, tingling, or nerve-related symptoms may develop.
Reduced white blood cell counts may increase susceptibility to infections.
Seek immediate medical attention if you experience:
Patients should contact their healthcare provider immediately if serious symptoms occur.
The dosage of CISLIEVA 10 MG (Cisplatin Injection IP 10 mg) should always be determined by a qualified oncologist.
Treatment recommendations vary according to the cancer being treated.
Dosage is generally calculated according to body surface area.
Renal function is an important factor in treatment planning.
Combination chemotherapy regimens may influence dosage schedules.
Blood counts and electrolyte levels help guide treatment decisions.
Before starting treatment, inform your doctor if you have:
Patients receiving Cisplatin therapy may require:
Patients should also disclose all prescription medicines, vitamins, supplements, and herbal products they are taking to avoid potential drug interactions.
Pregnant and breastfeeding women should not use this medicine unless specifically advised by a healthcare professional.
It is used for the treatment of testicular cancer, ovarian cancer, bladder cancer, lung cancer, head and neck cancer, cervical cancer, and other solid tumors.
Cisplatin is a platinum-based chemotherapy medicine that damages cancer cell DNA and prevents tumor growth.
Yes. Cisplatin is a widely used platinum-based chemotherapy agent.
Hydration helps reduce the risk of kidney-related side effects associated with Cisplatin therapy.
Yes. Hearing changes, including tinnitus and hearing loss, may occur and require monitoring.
Yes. Kidney monitoring is essential throughout treatment.
Yes. The medicine may lower white blood cells, red blood cells, and platelet counts.
Yes. This medicine should only be administered by qualified healthcare professionals experienced in oncology treatment.